市场调查报告书
商品编码
1576630
电脑辅助检测(CAD) 市场:按应用(肿瘤学、心臟病学)、按模态(乳房X 光摄影、MRI、CT、超音波)、最终用户(医院和诊所、诊断成像中心、门诊护理中心) - 直到2031 年世界预测Computer-aided Detection (CAD) Market by Application (Oncology, Cardiology), Modality (Mammography, MRI, CT, Ultrasound), End User (Hospitals & Clinics, Imaging Centers, Ambulatory Care Centers) - Global Forecast to 2031 |
到 2031 年,电脑辅助侦测 (CAD) 市场预计将达到 15.6 亿美元,2024 年至 2031 年的复合年增长率为 7.4%。
经过广泛的二次和初步研究以及对市场情景的详细分析,本报告对主要市场推动因素、阻碍因素、课题和机会进行了分析。这一增长是由于慢性病患病率不断上升、人们对早期癌症诊断重要性的认识不断提高、癌症研究投资和经费增加以及医疗保健成本增加。然而,CAD 解决方案的高成本限制了该市场的成长。
此外,CAD 解决方案的进步,例如放射科医生对CAD 的接受度提高、癌症筛检专案的增加以及人工智慧(AI) 和机器学习(ML) 的集成,预计将推动该市场的业务成长。然而,缺乏使用 CAD 系统所需的技术专业知识是影响市场成长的主要课题。
(註:提供上位5公司的SWOT分析)
Computer-aided Detection (CAD) Market by Application (Oncology [Breast, Lung, Colorectal, Liver], Cardiology), Modality (Mammography, MRI, CT, Ultrasound), End User (Hospitals & Clinics, Imaging Centers, Ambulatory Care Centers) - Global Forecast to 2031
The Computer-aided Detection (CAD) market is projected to reach $1.56 billion by 2031 at a CAGR of 7.4% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. This growth is due to the rising prevalence of chronic diseases, increasing awareness regarding the importance of early cancer diagnosis, increasing investments and funding for cancer research, and rising healthcare expenditure. However, the high costs of CAD solutions restrain the growth of this market.
Furthermore, the growing acceptance of CAD among radiologists, the increase in cancer screening programs, and advancements in CAD solutions, such as the integration of Artificial Intelligence (AI) and Machine Learning (ML), are expected to generate growth opportunities for the players operating in this market. However, the lack of technical expertise required to use CAD systems is a major challenge impacting market growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global Computer-aided Detection (CAD) market are Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), GE HealthCare Technologies Inc. (U.S.), Hologic, Inc. (U.S.), FUJIFILM Holdings Corporation (Japan), EDDA Technology, Inc. (U.S.), Canon Medical Systems Corporation (Japan), Riverain Technologies (U.S.), Median Technologies (France), Agfa-Gevaert NV (Belgium), iCAD Inc. (U.S.), CureMetrix, Inc. (U.S.), and THERAPIXEL (France).
Among all the applications studied in this report, in 2024, the oncology segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the increasing prevalence of breast cancer and the increase in breast cancer detection and awareness campaigns. Breast cancer ranks among the most prevalent cancers affecting women globally. According to the World Health Organization (WHO), 2.3 million breast cancer cases were recorded globally in 2020, and this number is expected to reach 3 million by 2040. The rising incidence of breast cancer has led to a rapid increase in the adoption of innovative technologies, such as CAD, aimed at enhancing breast cancer detection through a combination of various modalities.
Among all the imaging modalities studied in this report, in 2024, the mammography segment is expected to account for the larger share of the Computer-aided Detection (CAD) market. Computer-aided mammograms offer improved accuracy in diagnosis as the images can be zoomed in on, upgraded, or adjusted for more in-depth evaluation. Also, computer-aided mammography enables early identification of breast cancer in patients with no symptoms. These factors contribute to the segment's large share.
Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the Computer-aided Detection (CAD) market. The segment's large share is attributed to the rising prevalence of cancer, the growing number of hospitals and clinics, the availability of highly skilled professionals in hospitals and clinics, the high purchasing power of hospitals, and the increasing patient population seeking comprehensive healthcare services, including diagnosis, treatment, and surgical procedures.
An in-depth analysis of the geographical scenario of the global Computer-aided Detection (CAD) market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of the Computer-aided Detection (CAD) market. In the region in 2024, the U.S. is expected to account for the largest share of the Computer-aided Detection (CAD) market in North America. The large share of this regional market is attributed to the presence of major Computer-aided Detection (CAD) companies such as GE HealthCare Technologies Inc. (U.S.), and Hologic, Inc. (U.S.), increasing cancer cases, and technological advancements in cancer detection and diagnosis.
Computer-aided Detection (CAD) Market Assessment-by Application
Note: Other applications include neurology, diabetic retinopathy, and tuberculosis.
Computer-aided Detection (CAD) Market Assessment-by Imaging Modality
Note: Other imaging modalities include X-ray imaging and endoscopy.
Computer-aided Detection (CAD) Market Assessment-by End User
Computer-aided Detection (CAD) Market Assessment-by Geography
(Note: SWOT analyses of the top 5 companies will be provided.)